The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

Some people with autism spectrum disorder (ASD) have abnormal levels of glutamate in the brain. New research led by Mass General Brigham has focused on this neuron-activating chemical, suggesting that ...

At first glance, Alzheimer's disease and cancer have little in common. One erodes memory, while the other consumes the body. Yet researchers at MUSC Hollings Cancer Center have discovered an ...

In the rush to harness Alzheimer’s for guaranteed pathos, Bollywood often reduces the condition to a narrative convenience. And while this may deliver a high-voltage climax, it rarely does justice to ...

Lyndsey Collins-Praino receives funding from the National Health and Medical Council, the Medical Research Future Fund, the Australian Research Council and various philanthropic organisations. In ...

The Walk to End Alzheimer’s in Grand Rapids Saturday will help raise money for research being conducted at the Michigan State University College of Human Medicine.

Could Gum Health Protect Your Brain? What Athletes Should Know When you think about Alzheimer's disease, the first thing that comes to mind is probably memory l ...

A new study suggests fat deposits in the brain may play a larger role in Alzheimer's disease than previously thought. This could open a new avenue for potential treatment.

GROSSE POINTE FARMS, Mich. (FOX 2) - A Grosse Pointe Farms woman with Alzheimer’s disease is missing. Police reported that 65-year-old Janet Michels left her home on Colonial Court near Mack Avenue on ...

The Indianapolis community will take strides toward a future without Alzheimer’s on Saturday, Oct. 4, during the annual Walk to End Alzheimer’s ...

Alzheimer's disease, the most common form of dementia, affects millions of people worldwide and still has no definitive cure, although many researchers are in the race to find one.

The evidence is crystal clear: the largest barrier to Alzheimer’s treatment in Latino communities is the stigma associated with cognitive decline.